Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
COPZ2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
RABL2A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
WDR77 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ADRA2C - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WIPI2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLMN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESR1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BTBD11 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
AGO1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BMP8A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC43 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TP53I3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GFRA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AHI1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KAZN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RNF7 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UROS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on